雜志介紹

Drug Safety雜志介紹

《Drug Safety》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱藥物安全，本刊主要出版、報道醫(yī)學-PHARMACOLOGY & PHARMACY領域的研究動態(tài)以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業(yè)的最新進展，探討行業(yè)發(fā)展的思路和方法，以促進學術信息交流，提高行業(yè)發(fā)展。該刊已被國際權威數(shù)據(jù)庫SCIE收錄，為該領域相關學科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為4，最新CiteScore 指數(shù)為7.6。

本刊近期中國學者發(fā)表的論文主要有：

• A Population-Based Study of SGLT2 Inhibitor-Associated Postoperative Diabetic Ketoacidosis in Patients with Type 2 Diabetes

  Author: Lui, David Tak Wai; Wu, Tingting; Au, Ivan Chi Ho; Liu, Xiaodong; Fung, Matrix Man Him; Lee, Chi Ho; Fong, Carol Ho Yi; Woo, Yu Cho; Lang, Brian Hung Hin; Tan, Kathryn Choon Beng; Wong, Carlos King Ho

• Potential Approaches to Ameliorate Hepatic Fat Accumulation Seen with MTP Inhibition

  Author: Minjie Lin, Shuiping Zhao, Li Shen, Danyan Xu

• Dosage Effects of Histamine-2 Receptor Antagonist on the Primary Prophylaxis of Non-Steroidal Anti-Inflammatory Drug (NSAID)-Associated Peptic Ulcers: A Retrospective Cohort Study

  Author: Ying He, Esther W. Chan, Kenneth K. C. Man, Wallis C. Y. Lau, Wai K. Leung, Lai M. Ho, Ian C. K. Wong

• Pharmacovigilance in China: Current Situation, Successes and Challenges

  Author: Li Zhang, Lisa Y. L. Wong, Ying He, Ian C. K. Wong

英文介紹

Drug Safety雜志英文介紹

Drug Safety is the official journal of the International Society of Pharmacovigilance. The journal includes:

Overviews of contentious or emerging issues.

Comprehensive narrative reviews that provide an authoritative source of information on epidemiology, clinical features, prevention and management of adverse effects of individual drugs and drug classes.

In-depth benefit-risk assessment of adverse effect and efficacy data for a drug in a defined therapeutic area.

Systematic reviews (with or without meta-analyses) that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.

Original research articles reporting the results of well-designed studies in disciplines such as pharmacoepidemiology, pharmacovigilance, pharmacology and toxicology, and pharmacogenomics.

Editorials and commentaries on topical issues.

Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Drug Safety Drugs may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.